Skip to content
Lower risk Medical device recall · FDA · Published December 2, 2020

Siemens Atellica IM 130: Software issues may cause inaccurate test results

Siemens Healthcare recalls Atellica IM 1300 analyzers with software v1.23.2 or lower that may report inaccurate patient test results. Affected units include those with specific material numbers.

🇺🇸 FDA recall #Z-0862-2021Medical deviceSiemens Healthcare ›
Take action

Contact the company

Recalling firmSiemens Healthcare Diagnostics, Inc.511 Benedict Ave · Tarrytown, NY 10591-5005
✎ GovInfoNow plain-language explainer

Siemens Healthcare is recalling Atel:lica IM 1300 analyzers that have software versions 1.23.2 or older. These versions may cause inaccurate patient test results, which could lead to incorrect medical diagnoses. Read more at govinfonow.com/recall/63726-siemens-atellica-im-130-software-issues-may-cause-inaccurate-test.

Source Summary by GovInfoNow · govinfonow.com/recall/63726-siemens-atellica-im-130-software-issues-may-cause-inaccurate-test · Updated August 19, 2026 · FDA enforcement record: FDA #Z-0862-2021

Cite this page

“Siemens Atellica IM 130: Software issues may cause inaccurate test results.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/63726-siemens-atellica-im-130-software-issues-may-cause-inaccurate-test. Based on FDA recall #Z-0862-2021 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0862-2021%22&limit=1).

The FDA announced on Dec. 2, 2020, that Siemens Healthcare Diagnostics is recalling Atellica IM 1300 Analyzers with software version V1.23.2 or lower due to potential discrepant patient results. The agency classified the recall as Class II.

How to tell if you have it

  • Brand: Siemens Healthcare
  • Product: Atellica IM 1300 Analyzer
  • Siemens Material Number (SMN): 11066001
  • Software versions: V1.23.2 or lower

The hazard

Multiple issues in the affected software may lead to the reporting of discrepant patient results during in vitro diagnostic testing of clinical specimens.

Context

GovInfoNow's records show Siemens Healthcare Diagnostics has 150 other recalls on record since June 7, 2017. Other recent recalls of similar products include Siemens Atellica CH RCRP Test (Aug. 17, 2026), Beckman Coulter Emit 2000 Quinidine Assay (July 13, 2026), and Siemens Atellica CH Urine Albumin Recall (July 6, 2026). Additional recent recalls include Roche cobas pro integrated solutions (Jan. 20, 2026), DxC 500i Clinical Analyzer Modules (Sept. 2, 2026), and Siemens CT Software Applications (Dec. 19, 2025).

How to tell if you have this one

Check if your Atellica IM 1300 analyzer has software version 1.23.2 or lower. The product uses Siemens Material Number (SMN) 11066001.

  • Brand
    Siemens Healthcare
  • Category
    Medical device
FDA recall event · 3 products

All 3 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Terminated
  • Distribution
    Worldwide distribution - US Nationwide distribution and the countries of Algeria, Argentina, Australia, Austria, Bahrain, Bangladesh, Belgium, Brazil, Bulgaria, Canada, Chile, Colombia, Croatia, Cura¿ao, Cyprus, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Hungary, India, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Japan, Jordan, Kenya, Kuwait, Latvia, Libya, Lithuania, Malaysia, Mexico, Netherlands, New Zealand, Norway, Oman, P.R. China, Pakistan, Peru, Poland, Portugal, Qatar, Republic Korea, Romania, Russian Fed. Saudi Arabia, Singapore, Slovakia, Slovenia, South Africa, Spain, Sweden, Switzerland, Taiwan, Thailand, Turkey, U.A.E. Ukraine, United Kingdom, Uruguay, Vatika City, Vietnam.
Recall numberProduct, codes & lotsQuantity
Z-0861-2021Atellica CH 930 Analyzer - In vitro diagnostic testing of clinical specimens. Product Siemens Material Number (SMN): 11067000 - Product Usage: intended for the qualitative and quantitative analysis of various body fluids, using photometric, turbidimetric, chemiluminescent, and integrated ion selective electrode technology for clinical use.; Software (SW) versions V1.23.2 (SMN 11469032) or lower2405 units
Z-0862-2021Atellica IM 1300 Analyzer - In vitro diagnostic testing of clinical specimens. Product Siemens Material Number (SMN): 11066001 - Product Usage: intended for the qualitative and quantitative analysis of various body fluids, using photometric, turbidimetric, chemiluminescent, and integrated ion selective electrode technology for clinical use.; Software (SW) versions V1.23.2 (SMN 11469032) or lower1095 units
Z-0863-2021Atellica IM 1600 Analyzer - In vitro diagnostic testing of clinical specimens. Product Siemens Material Number (SMN): 11066000 - Product Usage: intended for the qualitative and quantitative analysis of various body fluids, using photometric, turbidimetric, chemiluminescent, and integrated ion selective electrode technology for clinical use.; Software (SW) versions V1.23.2 (SMN 11469032) or lower1588 units
Based on the official FDA remedy

What to do — step by step

  1. Update Software

    Contact Siemens Healthcare to update the software to version 1.23.3 or higher.

Where it went and when

Where it was distributed

Distributed nationwide, and outside the U.S.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Worldwide distribution - US Nationwide distribution and the countries of Algeria, Argentina, Australia, Austria, Bahrain, Bangladesh, Belgium, Brazil, Bulgaria, Canada, Chile, Colombia, Croatia, Cura¿ao, Cyprus, Czech Republic, Denmark,…” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide, and outside the U.S.

Recall timeline

FDA terminated this recall 3.5 years after the firm started it.

1. Firm started the recall: Dec 2, 202012. FDA classified it Class II: Jan 14, 202123. Published in FDA’s Enforcement Report: Jan 20, 202134. FDA terminated the recall: Jun 6, 2024420202024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-0862-2021 (December 2, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-0862-2021 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA